Tobacco Control

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Tobacco Control 2006;15(Supplement 4 ):iv98-iv106; doi:10.1136/tc.2004.009647
Copyright © 2006 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chaiton, M.
Right arrow Articles by LeGresley, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chaiton, M.
Right arrow Articles by LeGresley, E.

RESEARCH PAPER

Perceptions of industry responsibility and tobacco control policy by US tobacco company executives in trial testimony

Michael Chaiton1, Roberta Ferrence1,*, Eric LeGresley2

1 Department of Public Health Sciences, University of Toronto, Toronto, Ontario, Canada
2 Tobacco Control Consultant, Canada

Correspondence to:
Michael Chaiton
c/o Ontario Tobacco Research Unit, 33 Russell Street, Toronto, M5S 1A8 Canada; michael.chaiton{at}utoronto.ca

Objective: Trial testimony from the United States provides a unique opportunity to examine strategies of the American tobacco industry. This paper examines congruence between the arguments for tobacco control policy presented by representatives of the American tobacco industry at trial and the stages of responsibility associated with corporate social responsibility principles in other industries.

Data sources: Trial testimony collected and coded by the Deposition and Trial Testimony Archive (DATTA).

Study selection: All available testimony was gathered from representative senior staff from major tobacco companies: Brown & Williamson, Philip Morris, RJ Reynolds, and Liggett.

Data extraction: Transcripts from each witness selected were collected and imported in text format into WinMax, a qualitative data program. The documents were searched for terms relating to tobacco control policies, and relevant terms were extracted. A hand search of the documents was also conducted by reading through the testimony. Inferred responsibility for various tobacco control policies (health information, second-hand smoking, youth smoking) was coded.

Data synthesis: The level of responsibility for tobacco control policy varied according to the maturity of the issue. For emerging issues, US tobacco company representatives expressed defensiveness while, for more mature issues, such as youth smoking, they showed increased willingness to deal with the issue. This response to social issues is consistent with corporate social responsibility strategies in other industries.

Conclusion: While other industries use corporate social responsibility programmes to address social issues to protect their core business product, the fundamental social issue with tobacco is the product itself. As such, the corporate nature of tobacco companies is a structural obstacle to reducing harm caused by tobacco use.


Abbreviations: CSR, corporate social responsibility; DATTA, Deposition and Trial Testimony Archive; FTC, Federal Trade Commission; WHO, World Health Organization

Keywords: social responsibility; trial documents; tobacco control policy




This article has been cited by other articles:


Home page
Tobacco ControlHome page
D D. Blanke and H. H Humphrey III
Putting truth into action: using the evidence for justice
Tob. Control, December 1, 2006; 15(suppl_4): iv1 - iv3.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 by the BMJ Publishing Group Ltd.